US 11401506
Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy
granted A61KA61K2239/49A61K2239/57
Quick answer
US patent 11401506 (Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy) held by Board nf Regents The Inivercitvof Texas Cvctom expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Board nf Regents The Inivercitvof Texas Cvctom
- Grant date
- Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2239/49, A61K2239/57, A61K40/11, A61K40/36